Jim Woody

Jim Woody

Chief Executive Officer bei 180 LIFE SCIENCES CORP.

Vermögen: 5 138 $ am 31.03.2024

81 Jahre
Health Technology
Consumer Services
Finance

Profil

Jim N.
Woody
was the founder of OncoMed Pharmaceuticals, Inc. (founded in 2004) and held the title of Independent Director.
He is currently the Chief Executive Officer at 180 Life Corp., Chief Executive Officer & Director at 180 Life Sciences Corp., Executive Chairman at Enosi Life Sciences Corp., Vice Chairman at MARABio Systems, Inc., Director at InterLink AI, Inc., Director at Lucile Salter Packard Children's Hospital at Stanford, and Director at Viracta Subsidiary, Inc. He was previously the Partner and General Partner at Latterell Venture Partners (since 2005).
Dr. Woody's former positions include Chief Executive Officer & Director at KBL Merger Corp.
IV, Director at Bayhill Therapeutics, Inc., Director at Avidia, Inc., Director at Talima Therapeutics, Inc., Independent Director at TetraLogic Pharmaceuticals Corp., Director at IntegenX, Inc., Director at Calistoga Pharmaceuticals, Inc., Director at Proteolix, Inc., Director at ProteinSimple, Director at ForteBio, Inc., Director at Pharmix Corp., Director at HemaQuest Pharmaceuticals, Inc., Director at Femta Pharmaceuticals, Inc., Director at Neuraltus Pharmaceuticals, Inc., Director at Naval Medical Research Center, CSO, SVP-Research & Development at Centocor, Inc., President at Roche Palo Alto LLC, Chief Scientific Officer at Janssen Biotech, Inc., and President & General Manager at Roche Bioscience.
Dr. Woody's education includes an undergraduate degree from Andrews University, a doctorate degree from the University of London, a doctorate degree from Loma Linda University, and another doctorate degree from the University of London.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
18.12.2023 2 205 ( 0,26% ) 5 138 $ 31.03.2024

Aktive Positionen von Jim Woody

UnternehmenPositionBeginn
180 LIFE SCIENCES CORP. Chief Executive Officer -
Private Equity Investor 01.01.2005
Director/Board Member 17.04.2023
Chairman 01.07.2020
Chief Executive Officer 09.11.2020
Director/Board Member -
Director/Board Member 14.09.2020
Director/Board Member -
Alle aktiven Positionen von Jim Woody

Ehemalige bekannte Positionen von Jim Woody

UnternehmenPositionEnde
Director/Board Member 01.12.2019
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Jim Woody im Detail an

Ausbildung von Jim Woody

Andrews University Undergraduate Degree
University of London Doctorate Degree
Loma Linda University Doctorate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Jim Woody im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

31

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen2
TETRALOGIC PHARMACEUTICALS CORPORATION

Health Technology

180 LIFE SCIENCES CORP.

Health Technology

Private Unternehmen26

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Naval Medical Research Center

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Sehen Sie sich die Unternehmensverbindungen an